Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Warnings Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Storage Patient Counseling Information MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Full Prescribing Info

Indications/Uses

LATUDA is indicated for: 20-mg tab: Treatment of adult and adolescent patients aged 15 to 17 years with schizophrenia [see Pharmacology: Pharmacodynamics: Clinical Studies: Schizophrenia under Actions]; Monotherapy treatment of adult and adolescent (13 to 17 years) patients with major depressive episode associated with bipolar I disorder (bipolar depression) [see Pharmacology: Pharmacodynamics: Clinical Studies: Depressive Episodes Associated with Bipolar I Disorder under Actions]; Adjunctive treatment with lithium or valproate in adult patients with major depressive episode associated with bipolar I disorder (bipolar depression) [see Pharmacology: Pharmacodynamics: Clinical Studies: Depressive Episodes Associated with Bipolar I Disorder under Actions].
40- & 80-mg tab: Treatment of adult and adolescent patients aged 15 to 17 years with schizophrenia [see Pharmacology: Pharmacodynamics: Clinical Studies: Schizophrenia under Actions].

Latuda Indications/Uses

lurasidone

Manufacturer:

Sumitomo Pharma

Distributor:

DKSH